HOW OUTCOME MEASURES IN RHEUMATOID ARTHRITIS CLINICAL TRIALS WORKS TO DEVELOP OUTCOME MEASURES IN RHEUMATOLOGY CLINICAL TRIALSI116. CHOOSING AND DEVELOPING CORE OUTCOME MEASUREMENT SETS FOR CLINICAL TRIALS: OUTCOME MEASURES IN RHEUMATOID ARTHRITIS CLINICAL TRIALS FILTER 2.0

Rheumatology ◽  
2017 ◽  
Vol 56 (suppl_2) ◽  
Author(s):  
Maarten Boers
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trials ◽  
Outcome Measures ◽  
Outcome Measurement ◽  
Core Outcome

scholarly journals Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group

2017 ◽  
Vol 44 (5) ◽  
pp. 697-700 ◽  
Author(s):  
Alexis Ogdie ◽  
Maarten de Wit ◽  
Kristina Callis Duffin ◽  
Willemina Campbell ◽  
Jeffrey Chau ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Psoriatic Arthritis ◽  
Outcome Measures ◽  
Working Group ◽  
Development Process ◽  
Outcome Measurement ◽  
Core Outcome ◽  
Core Domain ◽  
Core Set ◽  
Core Domain Set

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group recently published the updated 2016 psoriatic arthritis (PsA) core domain set, a set of disease features that should be measured in all clinical trials. At the GRAPPA annual meeting in July 2016, the PsA working group presented the updated PsA core domain set endorsed by 90% of participants at OMERACT in May 2016 and drafted a roadmap for the development of the PsA core outcome measurement set. In this manuscript, we review the development process of the PsA core domain set and the ongoing and proposed work streams for development of a PsA core measurement set.

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

Pain ◽  
2005 ◽  
Vol 113 (1) ◽  
pp. 9-19 ◽  
Author(s):  
Robert H. Dworkin ◽  
Dennis C. Turk ◽  
John T. Farrar ◽  
Jennifer A. Haythornthwaite ◽  
Mark P. Jensen ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Clinical Trials ◽  
Outcome Measures ◽  
Core Outcome ◽  
Core Outcome Measures

scholarly journals Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)

2014 ◽  
Vol 171 (6) ◽  
pp. 1318-1325 ◽  
Author(s):  
J.R. Chalmers ◽  
J. Schmitt ◽  
C. Apfelbacher ◽  
M. Dohil ◽  
L.F. Eichenfield ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Outcome Measures ◽  
Atopic Eczema ◽  
Consensus Meeting ◽  
Core Outcome ◽  
International Consensus ◽  
The Third ◽  
Core Outcome Measures

scholarly journals OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies

2019 ◽  
Vol 46 (8) ◽  
pp. 1021-1027 ◽  
Author(s):  
Maarten Boers ◽  
Dorcas E. Beaton ◽  
Beverley J. Shea ◽  
Lara J. Maxwell ◽  
Susan J. Bartlett ◽  
...  
Keyword(s):  
Conceptual Framework ◽  
Outcome Measures ◽  
Intervention Studies ◽  
Outcome Measurement ◽  
Core Outcome Set ◽  
Health Intervention ◽  
Health Conditions ◽  
Core Outcome ◽  
Outcome Set ◽  
Core Set

Objective.The Outcome Measures in Rheumatology (OMERACT) Filter 2.0 framework was developed in 2014 to aid core outcome set development by describing the full universe of “measurable aspects of health conditions” from which core domains can be selected. This paper provides elaborations and updated concepts (OMERACT Filter 2.1).Methods.At OMERACT 2018, we discussed challenges in the framework application caused by unclear or ambiguous wording and terms and incompletely developed concepts.Results.The updated OMERACT Filter 2.1 framework makes benefits and harms explicit, clarifies concepts, and improves naming of various terms.Conclusion.We expect that the Filter 2.1 framework will improve the process of core set development.

scholarly journals Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development

2019 ◽  
Vol 46 (8) ◽  
pp. 1041-1046 ◽  
Author(s):  
Susan Humphrey-Murto ◽  
Richard Crew ◽  
Beverley Shea ◽  
Susan J. Bartlett ◽  
Lyn March ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Outcome Measures ◽  
Core Outcome Set ◽  
Delphi Process ◽  
Consensus Building ◽  
Core Outcome ◽  
Delphi Consensus ◽  
International Consensus ◽  
Work In Progress ◽  
Outcome Set

Objective.Developing international consensus on outcome measures for clinical trials is challenging. The following paper will review consensus building in Outcome Measures in Rheumatology (OMERACT), with a focus on the Delphi.Methods.Based on the literature and feedback from delegates at OMERACT 2018, a set of recommendations is provided in the form of the OMERACT Delphi Consensus Checklist.Results.The OMERACT delegates generally supported the use of the checklist as a guide. The checklist provides guidance for clearly outlining the multiple aspects of the Delphi process.Conclusion.OMERACT is deeply committed to consensus building and these recommendations should be considered a work in progress.

FRI0521 A framework and process to develop core outcome measurement sets for clinical trials in rheumatology: omeract filter 2.0

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A550.3-A551
Author(s):  
M. Boers ◽  
J. R. Kirwan ◽  
G. Wells ◽  
D. Beaton ◽  
L. Gossec ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Outcome Measurement ◽  
Core Outcome
Sign in / Sign up

Export Citation Format

Share Document